Survey finds 78% of scientists expect AI to accelerate drug discovery this year

Endpoints Signal surveyed roughly 1,500 biopharma insiders about AI's near-term impact on drug discovery. The respondents included a broad mix of industry roles.

While scientists had been the most doubtful in the previous poll, the latest results show that 78% now believe AI will speed discovery within the year.

The updated survey reflects a shift in confidence among researchers, suggesting growing acceptance of AI tools in early-stage research.

If the trend holds, pharma companies may increase investment in AI platforms, which could influence development timelines and investor outlooks.